Cipla to replace Sun Pharma in Sensex
Mumbai: Sun Pharmaceuticals will be replaced by Cipla in the Sensex from May 3, according to a BSE announcement. In the 30-stock Sensex, Sun Pharma with a weightage of 1.05 percent (as on Friday) is third from last. Reliance Industries has the most weightage (13.37 percent) and ACC has the lowest (0.76 percent).
Shares of Sun Pharma closed down 0.05 percent at 
1,693 and Cipla shares were up 1.18 percent at 333.55 on the BSE on Friday. Some of the criteria for selection of stocks for the Sensex are trading frequency, final rank, market cap weightage and industry and sector representations.
Revisions have been made in the BSE 100, BSE 200 and the BSE 500 also, and these changes will be effective from March 29. In the BSE 100, Asian Paints, GlaxoSmithKline, Baja Finserv and MTNL will be excluded. Lupin, NHPC, Shriram Transport Finance Company and Ultra Tech Cement will be included.
1,693 and Cipla shares were up 1.18 percent at 333.55 on the BSE on Friday. Some of the criteria for selection of stocks for the Sensex are trading frequency, final rank, market cap weightage and industry and sector representations.
Revisions have been made in the BSE 100, BSE 200 and the BSE 500 also, and these changes will be effective from March 29. In the BSE 100, Asian Paints, GlaxoSmithKline, Baja Finserv and MTNL will be excluded. Lupin, NHPC, Shriram Transport Finance Company and Ultra Tech Cement will be included.